Clinical Trial

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Study acronym: CARISTA
Recruiting
View on ClinicalTrials.gov →
Summary
Thunderstorm asthma is a recurring public health emergency in South-Eastern Australia which occurs in springtime. The major identified risk factors for thunderstorm asthma is hay fever and allergy to ryegrass pollen. The goal of the CARISTA study is to identify the risk of springtime allergic and thunderstorm asthma in allergic adults living in South-Eastern Australia. To do this the investigators will recruit 530 people who have hay fever and test them for allergy to ryegrass pollen and undertake simple lung function testing. The investigators will ask study participants to complete a customised symptom tracker over the springtime pollen season for 2 consecutive years. The outcome the investigators are looking for is an asthma exacerbation or worsening asthma symptoms. This study will enable the investigators to identify indicators (biomarkers) of severe and moderate asthma exacerbations in order to identify those at risk of thunderstorm and seasonal asthma so protective treatments and strategies can be advised.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-02; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2025-08-27
Trial Details
NCT Number NCT07055542
Lead Sponsor University of Melbourne
Collaborators: The Alfred, Eastern Health, Austin Hospital, Melbourne Australia, Monash Medical Centre, Queensland University of Technology, Northern Hospital, Australia, Western Hospital, Australia, Melbourne Health
Conditions Allergic Asthma, Thunderstorm Asthma, Seasonal Allergic Rhinitis, Grass Pollen Allergy, Asthma Exacerbation Due to Thunderstorm, Asthma Acute
Enrollment 530 participants
Start Date 2025-08-27
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06